# A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

> **NCT05147233** · PHASE3 · COMPLETED · sponsor: **Oculis** · enrollment: 241 (actual)

## Conditions studied

- Inflammation Eye Pain
- Postoperative Cataract

## Interventions

- **DRUG:** OCS-01
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT05147233
- **Lead sponsor:** Oculis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-24
- **Primary completion:** 2023-06-22
- **Final completion:** 2023-07-03
- **Target enrollment:** 241 (ACTUAL)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05147233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05147233, "A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05147233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*